Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Zhyldyz Kabaeva"'
Autor:
Cassandre Labelle-Dumais, David J Dilworth, Emily P Harrington, Michelle de Leau, David Lyons, Zhyldyz Kabaeva, M Chiara Manzini, William B Dobyns, Christopher A Walsh, Daniel E Michele, Douglas B Gould
Publikováno v:
PLoS Genetics, Vol 7, Iss 5, p e1002062 (2011)
Muscle-eye-brain disease (MEB) and Walker Warburg Syndrome (WWS) belong to a spectrum of autosomal recessive diseases characterized by ocular dysgenesis, neuronal migration defects, and congenital muscular dystrophy. Until now, the pathophysiology of
Externí odkaz:
https://doaj.org/article/798ef0f45e0e4478b76850bff3d09afd
Autor:
Tiffaney Tran, Peggy R. Cyr, Alex Verdieck, Miranda D. Lu, Hadjh T. Ahrns, Elizabeth G. Berry, William Bowen, Ralph P. Braun, Joshua M. Cusick-Lewis, Hung Q. Doan, Valerie L. Donohue, Deborah R. Erlich, Laura K. Ferris, Evelyne Harkemanne, Rebecca I. Hartman, James Holt, Natalia Jaimes, Timothy A. Joslin, Zhyldyz Kabaeva, Tracey N. Liebman, Joanna Ludzik, Ashfaq A. Marghoob, Isac Simpson, Jennifer A. Stein, Daniel L. Stulberg, Isabelle Tromme, Matthew J. Turnquist, Richard P. Usatine, Alison M. Walker, Bryan L. Walker, Robert F. West, Megan L. Wilson, Alexander Witkowski, Dominic J. Wu, Elizabeth V. Seiverling, Kelly C. Nelson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09d620c5d8ecb281b5387026f7e762ee
https://ruj.uj.edu.pl/xmlui/handle/item/309530
https://ruj.uj.edu.pl/xmlui/handle/item/309530
Autor:
Zhyldyz Kabaeva, Scott A. Flanders, Nabil Fallouh, Helen McGuirk, Vineet Chopra, Christina Healy, Jennifer Meddings, Shawna N. Smith, Brian Salata
Publikováno v:
Thrombosis Research. 135:829-834
Background Peripherally inserted central catheters (PICCs) are associated with upper extremity-deep vein thrombosis (DVT). However, patterns, risk factors and treatment associated with this event remain poorly defined. Objective To determine patterns
Autor:
Carol S. Davis, Daniel E. Michele, Susan V. Brooks, Zhyldyz Kabaeva, John M. Hayes, Jessica D. Gumerson
Publikováno v:
Human Molecular Genetics. 22:757-768
Mutations in several glycosyltransferases underlie a group of muscular dystrophies known as glycosylation-deficient muscular dystrophy. A common feature of these diseases is loss of glycosylation and consequent dystroglycan function that is correlate
Publikováno v:
Human Molecular Genetics. 20:3346-3355
The abnormal glycosylation and loss of extracellular matrix receptor function of the protein dystroglycan (DG) lead to the development of muscular dystrophy and cardiomyopathy. Dystroglycan is an important receptor for extracellular matrix proteins,
Publikováno v:
American Journal of Physiology-Cell Physiology. 299:C1430-C1440
The glycosylation of dystroglycan is required for its function as a high-affinity laminin receptor, and loss of dystroglycan glycosylation results in congenital muscular dystrophy. The purpose of this study was to investigate the functional defects i
Publikováno v:
Circulation Research. 105:984-993
Rationale: Genetic mutations in a number of putative glycosyltransferases lead to the loss of glycosylation of dystroglycan and loss of its laminin-binding activity in genetic forms of human muscular dystrophy. Human patients and glycosylation defect
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 294:H1667-H1674
The characterization of cellular phenotypes of heart disorders can be achieved by isolating cardiac myocytes from mouse models or genetically modifying wild-type cells in culture. However, adult mouse cardiac myocytes show extremely low tolerance to
Autor:
Rainer Dietz, Bakytbek Imanov, Mirsaid M. Mirrakhimov, Karl Josef Osterziel, Nana Bit-Avragim, Bernard Hoffmann, Reinhard Geßner, Dinara A. Usupbaeva, Raisa I. Rudenko, Andreas Perrot, Zhyldyz Kabaeva, Hajo Schmidt-Traub, Michal Tendera, Matthias Prager, Anna Wycisk, Heiko Witt
Publikováno v:
Journal of Molecular Medicine. 83:468-477
Hypertrophic cardiomyopathy (HCM) is a frequent, autosomal-dominant cardiac disease and manifests predominantly as left ventricular hypertrophy. Mutations in the cardiac beta-myosin heavy chain gene (MYH7) are responsible for the disease in about 30%
Autor:
Correia Jm, Andreas Perrot, Zhyldyz Kabaeva, Bastian Wolter, Karl Josef Osterziel, Nuno Cardim, Almaz Aldashev, Rainer Dietz, Mirsaid M. Mirrakhimov, Hagen D. Schulte
Publikováno v:
European Journal of Human Genetics. 10:741-748
Hypertrophic cardiomyopathy (HCM) can be caused by mutations in genes encoding for the ventricular myosin essential and regulatory light chains. In contrast to other HCM disease genes, only a few studies describing disease-associated mutations in the